FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting BREAKING NEWS: HHS Secretary Kennedy just announced that the FDA is taking a step toward restoring science based access by removing 12 peptides from Category 2 and advancing them for formal review. FDA considers adding a dozen peptides to its bulk drug compounding list RAPS BREAKING FDA UPDATE MASSIVE FOR PEPTIDES The U.S. Food & Drug Administration is reportedly reclassifying 14 peptides from Category 2 (compounding only, no legal prescribing) into Category 1. This means BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved